Article ; Online: Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations.
Multiple sclerosis and related disorders
2020 Volume 43, Page(s) 102224
MeSH term(s) | Adult ; Alemtuzumab/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Betacoronavirus ; COVID-19 ; Chile/epidemiology ; Coronavirus Infections/epidemiology ; Decision Making ; Female ; Fingolimod Hydrochloride/therapeutic use ; Glatiramer Acetate/therapeutic use ; Guideline Adherence ; Guidelines as Topic ; Health Behavior ; Humans ; Immunologic Factors/therapeutic use ; Interferons/therapeutic use ; Lymphocyte Count ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis, Chronic Progressive/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Natalizumab/therapeutic use ; Pandemics ; Pneumonia, Viral/epidemiology ; Quarantine ; SARS-CoV-2 ; World Health Organization ; Young Adult |
---|---|
Chemical Substances | Antibodies, Monoclonal, Humanized ; Immunologic Factors ; Natalizumab ; Alemtuzumab (3A189DH42V) ; Glatiramer Acetate (5M691HL4BO) ; Interferons (9008-11-1) ; ocrelizumab (A10SJL62JY) ; Fingolimod Hydrochloride (G926EC510T) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-05-23 |
Publishing country | Netherlands |
Document type | Letter ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2645330-7 |
ISSN | 2211-0356 ; 2211-0348 |
ISSN (online) | 2211-0356 |
ISSN | 2211-0348 |
DOI | 10.1016/j.msard.2020.102224 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.